; (B) by striking 0.6% and inserting 5% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (30) Spirotetramat Heading 9902.06.67 is amended— (A) by amending the article description to read as follows: [3-(2,5-Dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4.5]dec-3-en-4-yl] ethyl carbonate (Spirotetramat) (CAS No. 203313–25–1) (provided for in subheading 2933.79.08) ; (B) by striking 3.2% and inserting 1% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (31) Cyproconazole Heading 9902.06.77 is amended— (A) by amending the article description to read as follows: [α-(4-Chlorophenyl)-α-(1-cyclopropylethyl)-1H-1-1,2,4- triazole-1-ethanol (Cyproconazole) (CAS No. 94361–06–5) (provided for in subheading 2933.99.22) ; (B) by striking Free and inserting 1.3% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (32) Tebuconazole Heading 9902.06.78 is amended— (A) by amending the article description to read as follows: (RS)-1-p-Chlorophenyl-4,4-dimethyl-3-(1H-1,2,4-triazol-1- ylmethyl)pentan-3-ol (Tebuconazole) (CAS No. 107534–96–3) (provided for in subheading 2933.99.22) ; (B) by striking Free and inserting 4.4% ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (33) Metconazole Heading 9902.06.80 is amended— (A) by amending the article description to read as follows: 5-[(4-Chlorophenyl)methyl]-2,2-dimethyl-1-(1,2,4-triazol- 1-ylmethyl)cyclopentan-1-ol (Metconazole) (CAS No. 125116–23–6) (provided for in subheading 2933.99.22) ; (B) by striking 1.6% and inserting Free ; and (C) by striking 12/31/2020 and inserting 12/31/2024 . (34) Prothioconazole Heading 9902.06.81 is amended— (A) by amending the article description to read as follows: 2-[(2RS)-2-(1-Chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-2H-1,2,4-triazole-3(4H)-thione (Prothioconazole) (CAS No. 178928–70–6) (provided for in subheading 2933.99.22) ; (B) by striking 5.3% and inserting 5.7%